Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Preserve Access to Affordable Generics Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2010 · first_quarter · 1A
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| PFIZER, INC. |
| 13 |
| 2008–2010 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 13 | 2007–2010 |
| ASTRAZENECA PHARMACEUTICALS LP | 12 | 2007–2010 |
| GENENTECH INC | 12 | 2007–2009 |
| ELI LILLY AND COMPANY | 11 | 2007–2010 |
| MERCK | 11 | 2007–2010 |
| ABBOTT LABORATORIES | 9 | 2007–2009 |
| EISAI CORPORATION OF NORTH AMERICA | 9 | 2009–2010 |
| MCNEIL CONSUMER HEALTHCARE LLC | 9 | 2008–2009 |
| AMERICAN COLLEGE OF GASTROENTEROLOGY | 7 | 2009–2010 |
| NATIONAL VENTURE CAPITAL ASSOCIATION | 7 | 2008–2009 |
| PARTNERSHIP TO IMPROVE PATIENT CARE | 7 | 2008–2009 |
| BIOGEN IDEC INC. | 6 | 2007–2008 |
| CELL THERAPEUTICS INC | 6 | 2007–2008 |
| BRISTOL-MYERS SQUIBB | 5 | 2007–2008 |
| BECTON DICKINSON AND COMPANY | 3 | 2009 |
| NANOINK INC | 3 | 2008 |
| NOVARTIS | 3 | 2008–2010 |
| XDX INC | 3 | 2008 |
| PHOTOTHERA | 1 | 2008 |
Preserve Access to Affordable Generics Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515
Preserve Access to Affordable Generics Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Bill S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Bill S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act- HR 3590 Medicare Coveratge and Reimbursement Issue
American Middle Class Tax (AMT) Relief Act of 2007
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
American Middle Class Tax (AMT) Relief Act of 2007
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MEDIMMUNE INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: NOVARTIS · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: GLAXOSMITHKLINE · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PFIZER INC · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: CUBIST PHARMACEUTICALS · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMGEN · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: ELI LILLY AND COMPANY · Firm: FOLEY HOAG LLP
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Patent Reform Bills- S. 515, H.R. 1260
Patent Reform Bills- S. 515, H.R. 1260; Preserve Access to Affordable Generics Act, S.369
Patent Reform Act of 2009
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics, H.R.1427, H.R.1548 Patent Reform- S. 515, H.R. 1260 Health reform and Medicare payments
Patent Reform- S515, HR 1260
Patent Reform Act of 2009
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics, HR1427, HR1548 Patent Reform- S 515, HR 1260 Health reform, and Medicare payments for new technology
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Patent Reform Bills- S. 515, H.R. 1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act - S.369 Patent Reform Bill - S.515, H.R.1260
Patent Reform Act of 2009
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics - H.R.1427, H.R.1548, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patent Reform- S515, HR 1260
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Preserve Access to Affordable Generics Act, S.369; Patent Reform - S.515, H.R.1260
Patent Reform S 515, HR 1260
Patent Reform- S 515, HR 1260
Patent Reform Bills - S.515, H.R.1260 Preserve Access to Affordable Generics Act - S.369
Patent Reform S 515, HR 1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Patent Reform S 515, HR 1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Patent Reform Legislation - S 515, HR 1260
Patent Reform Act of 2009
Client: NATIONAL VENTURE CAPITAL ASSOCIATION · Firm: FOLEY HOAG LLP
Follow-on Biologics, HR1427, HR1548 Patent Reform- S 515, HR 1260 Health reform, and Medicare payments
Senate and House comprehensive health reform bills FDA regulations affecting MRSA products; FDA Hatch-Waxman and patent issues; Comparative effectiveness research; ARRA Patent Reform- S515, HR 1260 Follow-on biologics- HR1427, HR 1548
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515, H.R.1260
Patent Reform- S515, HR 1260
Patent Reform- S515, HR 1260
Patent Reform Act of 2009
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515, H.R.1260
Patent Reform- S 515, HR 1260
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Promoting Innovation and Access to Life-Saving Medicine Act
Client: EISAI CORPORATION OF NORTH AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SANOFI US SERVICES INC · Firm: FOLEY HOAG LLP
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: FOLEY HOAG LLP
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: FOLEY HOAG LLP
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 Physician Payment Sunshine Act S.301 ARRA; Comparative effectiveness research
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicare and Medicaid issues associated with the Patient Protection and Affordable Care Act of 2010, H.R. 3590 American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Bill S. 515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Medicare Coverage and Reimbursement Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Medicaid Rebate Issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2010 · second_quarter · Q2
Preserve to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Medicare and Medicaid coverage and reimbursement issues Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: Centers For Medicare and Medicaid Services (CMS)
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (Biosilimars) Re-authorization of the Prescription Drug User Fee Act (No Bill)
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (End Stage Renal Disease)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Q2
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2010 · second_quarter · Q2
Colorectal cancer Medicare and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
Medicare Coverage and Reimbursement
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Medicare and Medicaid coveraeg and reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Medicaid Rebate Issues
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2010 · first_quarter · Q1
Preserve Access to Affordable Generics Act- S. 369 Patent Reform- S. 515
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2010 · first_quarter · Q1
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S. 515
Medicare and Medicaid coverage and reimbursement issues
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: Centers For Medicare and Medicaid Services (CMS)
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2010 · first_quarter · Q1
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Patent Reform Bills- S. 515; Preserve Access to Affordable Generics Act, S.369
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2010 · first_quarter · Q1
Patient Protection and Affordable Care Act- HR 3590 Medicare Coveratge and Reimbursement Issue
Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2010 · first_quarter · Q1
Colorectal cancer Medicare and reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics HR 1427, HR 1548
Medicare Coverage and Reimbursement Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · second_quarter · 2A
Medicare Coverage and Reimbursement Issue
Follow-on Biologics H.R. 1427, H.R. 1548, S. 1695 Health care reform
ARRA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · 2@
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Medicare Improvements for Patients and Providers Act
Patent Reform Legislation - S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · 2@
Medicare Coverage and Reimbursement
Health Care Reform Follow-on Biologics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2@
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · 2@
Medicaid Rebate Issues FDA Globalization Act HR 759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
Patent Reform S 515, HR 1260
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3@
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · 3@
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · 4@
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · 2@
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · 4@
Matters relating to healthcare associated infections
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Patent Reform- S515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · 3A
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
Medicare and Medicaid coverage and reimbursement issues
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Medicare and Medicaid coverage and reimbursement issues
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
MCNEIL CONSUMER HEALTHCARE LLC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Non-Prescription Drug Modernization Act - HR 4083, S. 2317 FDA Globalization Act - HR 759
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2009 · first_quarter · 1A
Patent Reform, American Recovery and Reinvestment Act, Follow-on Biologics, Comparative Effectiveness Research work
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.___ America'sAffordable Health Choices Act Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S.301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · second_quarter · 2A
Patent Reform Legislation - S 515, HR 1260
FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER
Medicare Improvements for Patients and Providers Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · 2A
Health Care Reform Follow-on Biologics
Medicare Coverage and Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · second_quarter · 2A
American Recovery and Reinvestment Act Compartive Effectiveness Research programs and regulations S 1213 - The Patient-Centered Outcomes Research Act of 2009 HR 2502 - The Comparative Effectiveness Research Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Medicaid Rebate Issues FDA Globalization Act HR 759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
Follow-on Biologics HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548 Pathway for Biosimilars Act; Food and Drug legislation; Safe-guarding America's Pharaceutical Act; HR3200 House Health Care Reform bill
Patent Reform S 515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.___ Affordable Health Choices Act Patent Reform Legislation Comparative effectiveness research Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · second_quarter · 2A
Senate and House comprehensive health reform bills; S.__ Affordable Health Choices Act Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Matters relating to healthcare associated infections
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · second_quarter · 2A
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 Comprehensive healthcare reform; S.__ Affordable Health Choices Act; America's Affordable Health Choices Act- H.R. 3200
Patent Reform Bills- S. 515, H.R. 1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Medicare Coverage and Reimbursement Issue
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Patent Reform- S515, HR 1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Medicare Coverage and Reimbursement Issue
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · first_quarter · 1A
Patent Reform- S515, HR 1260
Follow-on Biologics- HR 1427, HR 1548 Physician Payments Sunshine Act- S301
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · first_quarter · 1A
Medicare Coverage and Reimbursement Issue
Follow-on Biologics HR 1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · 4A
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · 3A
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
American Recovery and Reinvestment Act; Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2502 ;Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Preserve Access to Affordable Generics Act - S.369 Patent Reform Bill - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R. 3590; Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 ARRA; Comparative effectiveness research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Q4
Medicare Coverage and Reimbursement
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Medicaid Rebate Issues; FDA Globalization Act - H.R.759 Pharmaceutical coverage and reimbursement issues associated with American Recovery and Reinvestment Act of 2009
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, S.1695.
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act - S.369 Patent Reform - S.515, H.R.1260
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 The Patient-Centered Outcomes Research Act - S.1213; Comparative effectiveness research - H.R.2505 Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548; Physician Payment Sunshine Act - S.301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Biosimilars Act of 2009 - H.R.1548 Promoting Innovation and Access to Life-saving Medicines Act - H.R.1427; Patient-Centered Outcomes Research Act - S.1213.
Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515
Medicare and Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS)
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Patient-Centered Outcomes Research Act - S.1213
Preserve Access to Affordable Generics Act - S. 369 Patent Reform - S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patent Reform Bills - S.515, H.R.1260 Preserve Access to Affordable Generics Act - S.369
FDA Globalization Act - H.R.759 Follow-on biologics - H.R.1427, H.R.1548 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590; Affordable Health Care for America Act - HR 3962 Biosimilars Follow-on Biologics - Promoting Innovation and Access to Life-Saving Medicine - H.R.1427 Pathway for Biosimilars Act- H.R.1548; Biologics Price Competition and Innovation Act of 2007- S.1695
Patient Protection and Affordable Care Act - H.R.3590 Medicare coverage and reimbursement Medicaid Drug Rebate Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Colorectal cancer Medicare coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Follow-on Biologics - H.R.1427, H.R.1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECTON DICKINSON AND COMPANY via FOLEY HOAG LLP
2009 · fourth_quarter · Q4
Matters relating to healthcare associated infections
Federal policies and legislations regarding utilization of diagnostic products and medical equipment; hospital-acquired infections Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL VENTURE CAPITAL ASSOCIATION via FOLEY HOAG LLP
2009 · third_quarter · Q3
Follow-on Biologics - H.R.1427, H.R.1548, S.1695; Patent Reform - S.515, H.R.1260 Health reform and Medicare payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · third_quarter · 3A
Follow-on Biologics H.R. 1427, H.R.154, S.1695
S. 1796, America's Healthy Future Act (Medicaid Drug Rebate Program); Medicare Coverage and Reimbursement Issue
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · third_quarter · Q3
S. 1796, America's Healthy Future Act (Medicaid Drug Rebate Program); Medicare Coverage and Reimbursement Issue
Follow-on Biologics H.R. 1427, H.R.154, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, H.R.1548 Physician Payment Sunshine Act, S.301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Comparative effectiveness research; patent reform Follow-on biologics legislation - H.R. 1427, H.R. 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA PHARMACEUTICALS LP via FOLEY HOAG LLP
2009 · third_quarter · Q3
Patent Reform Bills- S. 515, H.R. 1260; Preserve Access to Affordable Generics Act, S.369
FDA Globalization Act, H.R. 759 Follow-on biologics - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301 S.__ Affordable Healthy Futures Act; America's Affordable Health Choices Act- H.R. 3200
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBOTT LABORATORIES via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.__ Affordable Healthy Futures Act America's Affordable Health Choices Act H.R.3200 Follow-on biologics legislation - H.R. 1427, H.R. 1548 Physician Payments Sunshine Act - S. 301
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF GASTROENTEROLOGY via FOLEY HOAG LLP
2009 · third_quarter · Q3
Colorectal cancer Medicare coverage and reimbursement issues
S.___ Americas Healthy Futures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDIMMUNE INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
Medicaid Rebate Issues FDA Globalization Act H.R.759 Pharmaceutical coverage and reimbursement issues associated wtih American Recovery and Reinvestment Act of 2009
S.___ Affordable Healthy Futures Act Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695.
Preserve Access to Affordable Generics Act, S.369 Patent Reform S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EISAI CORPORATION OF NORTH AMERICA via FOLEY HOAG LLP
2009 · third_quarter · Q3
Medicare and Medicaid coverage and reimbursement issues
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200; Pathway for Biosimilars Act of 2009 H.R.1548, Promoting Innovation and Access to Life-saving Medicines Act H.R.1427; Patient-Centered Outcomes Research Act S.1213.
Preserve Access to Affordable Generics Act, S. 369 Patent Reform Act S.515
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PARTNERSHIP TO IMPROVE PATIENT CARE via FOLEY HOAG LLP
2009 · third_quarter · Q3
American Recovery and Reinvestment Act Comparative effectiveness research programs and regulations The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505 S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK via FOLEY HOAG LLP
2009 · third_quarter · Q3
Preserve Access to Affordable Generics Act, S.369; Patent Reform - S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics H.R.1427, S.1695
Medicare and Medicaid coverage and reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLAXOSMITHKLINE via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementation of pandemic, biodefense preparedness and Appropriations Legislation
Medicare and Medicaid coverage and reimbursement issues
Preserve Access to Affordable Generics Act, S.369 Patent Reform- S.515, H.R.1260
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via FOLEY HOAG LLP
2009 · third_quarter · Q3
Preserve Access to Affordable Generics Act, S.369 Patent Reform Bill S.515, H.R.1260
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, H.R.1548, S.1695 Physician Payment Sunshine Act S.301 ARRA; Comparative effectiveness research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Q3
Medicare Coverage and Reimbursement
S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics - H.R.1427, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Choices Act; Americas Affordable Health Choices Act H.R.3200 Follow-on Biologics- H.R.1427, H.R.1548 Physician Payments Sunshine Act- S.301
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2009 · third_quarter · Q3
S.___ Affordable Healthy Futures Act Americas Affordable Health Choices Act H.R.3200 Patient-Centered Outcomes Research Act S.1213
Preserve Access to Affordable Generics Act, S. 369. Patent Reform S.515
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · third_quarter · Q3
Medicare Coverage and Reimbursement Issue
S.___ Americas Healthy Futures Act; Follow-on Biologics H.R. 1427, H.R.154, S.1695
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC via FOLEY HOAG LLP
2009 · second_quarter · Q2
Follow-on Biologics- H.R. 1427, H.R. 1548, S1695 Physician Payments Sunshine Act- S.301 Health Care Reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CUBIST PHARMACEUTICALS via FOLEY HOAG LLP
2009 · second_quarter · Q2
Senate and House comprehensive health reform bills FDA regulations affecting MRSA products; FDA Hatch-Waxman and patent issues; Comparative effectiveness research; ARRA Patent Reform- S515, HR 1260 Follow-on biologics- HR1427, HR 1548
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN via FOLEY HOAG LLP
2009 · second_quarter · Q2
Medicare Coverage and Reimbursement Issue
ARRA
Follow-on Biologics H.R. 1427, H.R. 1548, S. 1695 Health care reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE